Graves’ disease treatment should be stopped only with the prescribing clinician’s guidance, not simply because you feel better. For antithyroid medicines such as methimazole or carbimazole, the clinician usually reviews thyroid blood tests, may check thyroid-receptor antibodies, and considers how long treatment has lasted before deciding whether to reduce and stop the dose. Blood tests after stopping are essential because the disease can return.
When can you safely stop Graves’ disease medication?
For many adults taking antithyroid medicines, stopping treatment becomes an option after about 12 to 18 months. However, the length of treatment alone does not determine whether stopping is appropriate. The decision depends on thyroid hormone levels, antibody test results, the response to treatment, and the person's medical history.
The American Thyroid Association explains that methimazole may be discontinued after 12 to 18 months when thyroid-stimulating hormone (TSH) and thyroid receptor antibodies (TRAb) are normal. If antibody levels remain elevated, remission is less likely, and continuing treatment may be a reasonable option. Some people benefit from longer-term treatment with a low dose rather than stopping at the end of the initial course.
Feeling well is encouraging, but it does not prove that Graves’ disease is in remission. Antithyroid medicines control the thyroid gland's hormone production while they are being taken. Remission means that the overactive thyroid does not return after the medicine is stopped. Because these are different outcomes, the decision should be based on blood tests and clinical assessment rather than symptoms alone.
Which blood tests are needed before stopping treatment?
Before deciding whether to stop an antithyroid medicine, your clinician will usually review tests that show how actively the thyroid is working. These commonly include TSH and free thyroxine (FT4), and sometimes triiodothyronine (T3). The results help determine whether thyroid hormone levels are controlled and whether further treatment or monitoring is needed.
Your clinician may also check TRAb, which measures antibodies that act on the thyroid and are associated with Graves’ disease. Lower or normal TRAb levels generally support a greater chance of remission, while persistently elevated levels may suggest a higher chance of the disease returning. No single result can predict the outcome with certainty, so the findings are considered alongside the duration of treatment and your medical history.
Bring your recent blood test results and medication details to the appointment. It is useful to know your current dose, how long you have been taking the medicine, whether your dose has changed recently, and whether you have experienced side effects. These details help the clinician plan the next steps instead of relying on one laboratory result.
Should you gradually reduce the dose or stop it at once?
There is no single stopping schedule that is suitable for everyone. Depending on the medicine and your test results, the clinician may gradually reduce the dose before stopping it or recommend a different plan. Do not lower your dose, take the medicine on alternate days, or stop it on your own in an attempt to see whether the disease has gone away.
The NHS guidance on carbimazole explains that the dose may be gradually lowered and then stopped once thyroid hormone levels are under control, but it also advises against stopping without first speaking to a doctor. If treatment is stopped too early, thyroid hormone levels may rise again, and symptoms can take time to return. Continue taking the prescribed dose until your clinician gives you a revised plan, unless urgent advice about a serious medicine reaction tells you otherwise.
What monitoring is needed after stopping medication?
Stopping antithyroid medication is the beginning of a monitoring period, not the end of follow-up. Graves’ disease can return even when blood tests were reassuring at the time treatment stopped. Regular testing helps identify a change in thyroid function before it causes more noticeable health problems.
The National Institute for Health and Care Excellence (NICE) recommends that adults have TSH testing within eight weeks of stopping antithyroid medication, then every three months for a year, followed by annual testing. The clinician may adjust the schedule according to your results, medical history, symptoms, or local guidance. Children and young people require a different follow-up plan that includes TSH, FT4, and T3 testing after treatment stops.
Arrange the first blood test before or at the time the medication is stopped, so the date is not missed. Keep future appointments even if you feel well. Tell your healthcare team if you develop new symptoms between scheduled tests, because you may need testing sooner than planned.
What signs may suggest Graves’ disease is returning?
After stopping treatment, pay attention to new or returning changes in how you feel. Possible signs of an overactive thyroid include a racing or irregular heartbeat, hand tremors, sweating or feeling unusually hot, difficulty sleeping, unexplained weight loss, and muscle weakness. These symptoms can have other causes, so they should not be used on their own to decide whether Graves’ disease has returned.
The Mayo Clinic's guidance on Graves’ disease describes these kinds of symptoms in connection with excess thyroid hormone. If they reappear or persist after treatment stops, contact your clinician and ask whether thyroid testing is needed. Do not restart leftover medication or change your dose without advice. Chest pain, fainting, or severe difficulty breathing requires urgent medical assessment.
Not everyone experiences an obvious return of symptoms. This is one reason follow-up blood tests remain important even when day-to-day health seems unchanged. Recurrence may lead to another course of antithyroid medication or a discussion of other treatment options, depending on the test results, previous treatment response, and personal circumstances.
When should you seek urgent advice about medication side effects?
Stopping treatment under a planned medical schedule is different from responding to a possible serious reaction to the medicine. Rarely, carbimazole can cause a dangerously low white blood cell count or liver problems. These reactions need prompt medical attention and should not be managed by waiting for your next routine appointment.
The NHS guidance on carbimazole side effects advises stopping carbimazole and contacting a doctor or urgent advice service immediately if you develop a high temperature, sore throat, mouth ulcers, severe tiredness, flu-like symptoms, or signs of an infection. Yellowing of the skin or eyes, or dark urine, also requires urgent medical advice because these can indicate liver problems. Follow the specific instructions given by the clinician assessing the reaction before taking further doses.
Does stopping treatment differ for children or during pregnancy?
Yes. Treatment duration and follow-up can differ by age and life stage. The European Thyroid Association guideline on Graves’ hyperthyroidism recommends a typical initial antithyroid treatment course of 24 to 36 months for children, compared with 12 to 18 months for many adults. Children should therefore have their stopping decision and monitoring plan managed by a clinician experienced in thyroid disease in young people.
Pregnancy or plans to become pregnant also need specific medical review. The choice and timing of antithyroid medication may change during pregnancy, so contact your endocrinologist or obstetric clinician before making any medication changes. Do not stop or switch treatment independently, because both medication exposure and uncontrolled thyroid hormone levels need careful consideration.
What if Graves’ disease was treated with radioactive iodine or surgery?
Stopping antithyroid medicine is not the same as stopping all thyroid-related treatment. Radioactive iodine and surgery are treatments that reduce or remove thyroid tissue. After either treatment, the thyroid may become underactive, and some people need long-term levothyroxine to replace the hormone their body no longer makes in sufficient amounts.
If you take levothyroxine after radioactive iodine or thyroid surgery, do not stop it simply because symptoms have improved. Your clinician will use thyroid function tests to decide whether the dose remains appropriate. Ask for clarification if you are unsure whether a prescription is an antithyroid medicine, which reduces thyroid hormone production, or thyroid hormone replacement, which supplies hormone the body needs.
How can you prepare for a safe stopping plan?
Before your next appointment, gather your recent thyroid test results, write down your current medicine and dose, and note any recent changes in symptoms. Ask whether your TSH, FT4, T3, and TRAb results support stopping, whether a dose reduction is needed, and when your first follow-up test should take place.
It is also helpful to confirm who will review your results and how you should contact the clinic if symptoms return. Keep a record of the planned blood test dates, and make sure you understand which symptoms need a routine appointment and which medicine reactions need urgent attention. A clear plan makes it easier to stop treatment safely while continuing to check for recurrence.